Mark D. Eisner
About Mark D. Eisner
Mark D. Eisner: Chief Medical Officer
Mark D. Eisner currently serves as the Chief Medical Officer. In this role, he oversees medical and clinical strategies, ensuring the highest standards in patient care and clinical operations. His extensive experience in the biopharmaceutical industry and academia provides a solid foundation for leadership in this capacity.
Mark D. Eisner's Educational Background
Mark D. Eisner earned an M.D. from the University of Pennsylvania School of Medicine. He also holds a Master's in Public Health (MPH) from the University of California, Berkeley. For his undergraduate studies, he completed a degree in human biology at Stanford University. His advanced training includes residency in internal medicine and fellowship in pulmonary and critical care medicine at the University of California, San Francisco.
Professional Background of Mark D. Eisner
Mark D. Eisner has built a distinguished career in both the academic and biopharmaceutical sectors. He began his career at Genentech, serving in various clinical and medical leadership roles, eventually becoming the Senior Vice President, Global Head of Immunology, Infectious Disease, and Ophthalmology Product Development. He also previously held the position of Executive Vice President and Chief Medical Officer at FibroGen.
Mark D. Eisner's Academic Contributions
For a decade, Mark D. Eisner served on the faculty of the University of California, San Francisco. He started as an Associate Professor of Medicine and Anesthesia, later becoming a Clinical Professor of Medicine. During his tenure, he significantly contributed to medical education and research, enhancing the institution's academic standards.